| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |